Dr. Nandu Deorkar, senior vice president, research & development at Avantor, addresses the manufacturing challenges that remain when developing cell and gene therapies at scale.
Fabio Bertacchini, Senior Director of Product, Proposal and Technical Account Management at Stevanato Group shares how Ready-To-Use vials are answering pharma's call for solutions to aseptic manufacturing challenges.
Kevin Doran, global head of supply chain at Tower Cold Chain, discusses the role and growing importance of last-mile delivery in the pharmaceutical cold chain.
Matthew Lowrie, quality assurance manager, Almac Clinical Technologies explores how the evolving regulatory guidance around data integrity is impacting clinical trial applications and data.
Zabir Macci, director of eCOA business strategy & sales engineering at IQVIA, describes how to navigate global regulatory guidance for successful multinational clinical trials.
Q&A with Kimberly Remillard, RAC, senior regulatory affairs manager at Thermo Fisher Scientific, examines how leveraging the power of Pharma 4.0 can ensure data integrity within biopharma.
Bruno Speder, VP of regulatory affairs & consultancy services, hVIVO, discusses how Human Challenge Trials (HCT) can be used in the framework of expedited review programs as part of drug and vaccine development.
Christian Merup, CEO of Wellma, explains the winning recipe for successful co-manufacturers in Europe, including the underlying threads and unique capabilities of the leaders in the current CDMO market.
Nick Porter, World Courier, and Chris Williams, Alloga Europe, discuss the heightened demand for cold chain and cryogenic storage to support advanced therapy medicinal products (ATMPs) and the solutions needed to safeguard the supply chain.
A new report published by Connect in Pharma highlights a range of forces shaping the future of the pharmaceutical manufacturing and drug-delivery fields, from machine learning and connected devices to eco-friendly strategies.
